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We have previously show" thai after peripheral nerve lesion 
the synthesis 0' NGF is induced in cells 01 the nerve sheath 
(Heumann el 81., 19878). Further analysis led 10 the identi-
flcation 01 growth factars and intracellular mechanisms re-
sponsible 10r this induction in sciatic fibroblasts (lind holm 
el 81., 1988; Hengerer el 81., 1990). The prese"t work aimed 
al the elucidation of the regulation 0' NGF synthesis in 
Schwan" cells. 
A variety 01 cytokines and peptide growth factors, includ-
ing interleukin- l (IL- t) and platelet-derived growth factor 
(PDGF), which are known 10 increase NGF-mRNA in 'ibro-
blasts and astrocytes, failed to do so in Schwann cell cul-
tures. Forskolin (FK), an activator 01 adenylate cycla8e, in-
creased the level o' NGF-mRNA eightfold within 3 hr of 
incubation. The effect of FK on NGF-mRNA was mimicked 
by analogs of cAMP but not by dideoxyforskolin. an FK de-
rivative not activating adenylate cyclase. Application 0' 
norepinephrine and isoproterenol also augmented the NGF-
mRNA content. Pretreatment of Schwann cells with N-(2-
(methylamlno)ethyll-S-isoquinoline sulfonamide dihydro-
chloride (H-8), an inhibitor 0' cyclic-nucleotide-dependent 
protein kinas.s, decreased both basal and elevated levels 
of NGF-mRNA. lonomycin, a Cau ionophore, and phorbol 
12-myristate 13-acetate (TPA), an aClivatoro' prote in kinase 
C, potentiated the effect of FK in an H-8-sensitive manner. 
We show that the action of FK is independent of changes in 
mRNA stability and of protein synthesis. Thus, in cultured 
Schwann cells upregulation Of NGF-mRNA expression seems 
to be mainly achieved by a cAMP-triggered transcriptional 
activation of the HGF gene. Another striking difference be-
tween various glial cell types was revealed by application 
of transforming growth factor 1J-1 (TGF-1J1), which i8 the 
strongest inducerof NGF-mRNA in cultured astrocytes (Lind-
holm el 81., 1990). Schwann cells responded 10 TGF-,81 by 
decreasing basal as weil 8S FK-induced NGF-mRNA levels. 
Tagether with previously published work, our reaults show 
that cell-type-specific mechanisms not only account 10r the 
different control of HGF expression in neurons .s compared 
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to glial cells, but also reveal a surprising specific ity of reg-
ulatory mechanisms in different non-neuronal cell types, even 
those derived ' rom the same tissue such as fibroblasts and 
Schwann cells of peripheral nerves. 
Schwann cell s are the glial cclls of the PNS. They play an es-
sential role in the formation of the microenvi ronment of the 
neuronal axons. Depending on thc propcrt ics ofthe axons, thcy 
form myelin sheaths or ensheath the axons in nonm yel inated 
form (Wei nbergand Spencer, 1975; Aguayo ct al. , 1976). Bcsides 
myclin prote ins, Schwann cells synthesize componcnts of the 
ex tracellu lar matrix (ßungcct al. , 1980; Carey et al. , 1983; Com-
brooks ct al. , 198J; McGarvey et aL, 1984; Mehta Cl al. , 1985), 
cell adhesion molecules (Nicke and Schachner, 1985: Noble cl 
al. , 1985 ; Dani10ff et al. , 1986), and also neurolrophie faetors 
such as NGF (Riehardson and Ebendal, 1982; Rush, 1984; As-
souline el al., 1987; ßand tlow ct al., 1987). In the adult sciatic 
nerve, the eontribution of the non-neuronal cells to the NGF 
supply for the NGF-depcndent (sympalhetieand subsets ofneu-
ral erest-derived sensory; for review, see Levi-Monta lcini and 
Angeleui, 1968; Thocncn and Barde, 1980) neurons is negligible 
(Heu mann Cl al. , 1987a). These neurons are troph icall y sup-
poned from their pcripheral target tissues. However, after nerve 
lesion there is a massive increase in the synthesis of NGF by 
thc scia tie non-neuronal cell s (Heumann el al., 1987a.b). ln situ 
hybridization experiments demonstrated that all the non-neu-
ronal cell s in the lesioncd seia lic nerve, in panicular Schwann 
cells and fibroblasts , express NGF-mRNA (Bandl10w el al., 198 7; 
Heumann el al. , 1987a). This 1csion-medialcd induetion ofNGF-
mRNA in the sciatic nerve occurs in a biphasic manner (Heu-
mann ct al. , 1987a). The secend prolonged incrcasc is eorrclated 
wi th the immigration of macrophages. A causal rclationship 
bctwccn these two phenomena eould be deduced from the fac t 
that in explants of sciatie nerve only the in itial and not the 
sceond prolonged inereasc in NGF-mRNA could be observed. 
However, the biphasic in vivo situation could be mimicktd by 
the addition ofaclivated maerophages (Heu man n et al. , 1987b), 
and in terleukin-I (lL- I) was identified as a mediator of this 
prolonged elevation of NGF-mRNA (Lindholm et al. , 1987). 
In fun her experiments, it has bcen demonstratcd that fibro-
blasts, di ssociated from adult rat sciatic nerve, also respond to 
IL- I by an inereasc in NGF-mRNA (Lindholm et al. , 1988). 
However, it was not c1ear whether NGF synthesis in Schwann 
cells, wh ich represent thc most abundant cell type of the scia tie 
nerve, is rcgulatcd in a simila r manner. 
In the present experiments, we ana1yzed in Schwann eell cul-
lure the effects cf those faeters and cytokines that have prcvi-
ousl)' bcen shown to incrcase NGF-mRNA in othcr cell types, 
particularly in fibroblasts and astrocytes. Moreover, we inves-
tigalcd thc e lreet ofSchwann cell-axon interactions a nd fina lly 
second messenger systems that could bc involvcd in thc regu-
lation of NG F-mRN A synthcsis in Schwann cclls. We repon 
that none of the growth factors and cYlokines tcstcd incrcased 
NGF-mR NA levels in Schwann cells; however, forskolin (FK; 
an aetivalor ofadenylate cyclase), cAMP derivatives, and ag-
onists of .6-adrenergie reeeplors produccd a markcd incrcasc in 
NGF-mRNA levels in Schwann eells. Transforminggrowth fac-
tor ß - I (T GF-ß I), the most powerful inducer of NGF-mRNA 
in astrocylc culturcs (Lindholm CI al. , 1990), not only did not 
inercasc the NGF-mRNA levels in Schwann eells, but even 
redueed the basal level and abolished the inercase initiated by 
FK in Schwann eells. 
Materials and Methods 
Ma/erial5. Dulbecco's modificd Eagle's medium (DMEM), Ham's FI2 
medium, Minima[ Essentia[ Medium (MEM), penicillin, streptomycin, 
poIY-L-lysine, eytosine.ß-D-arabinofuranosidc (Ara-C), mouse epider-
mal growth faetor (EGF). (± )-norepinephrine, ( - )-isoprotcrenol. 
{± }-metoprolol, clonidin, prostaglandin E:, fONkolin (7ß-aceloxy-8, 13-
cpoxy- Ia ,6ß.9a-trihydroxylabd-14-cne-II-one). ionomyein, phorbol 12-
myristate 13-acetate (TPA), eyclohexi mide, aetinomycin D, 8-bromo-
cAMP (8-Br-cAMp), N"-benzoyl-cAMP, and rat calci tonin gene-related 
peptide (CG RP) were purchased from Sigma (St. Louis). Human plate-
let~erivedgrowth faetor AB (PDGF-AB), poreine PDGF-BB. and TGF-
,6 1 were purehased from British BiO-lcchnology (Qxford), fetal calf 
serum (FCS) was from Boehringer Mannheim (Mannheim), 1-(5-iso-
quinolinesulfonyl)-2 -mClhylpiperazine dihydrochloride (H-7) and N-[2-
(mcthylamino )ethy[l-5-isoquinoline sul fonamide dihydrochloride (H -8) 
wert from Scikagaku Kogyo (Tokyo), and EHS [aminin was from GIB-
CO-BRL (Eggenstein, Gennany). We gt3lelil!ly acknowlcdge the gen-
erous gifls of the following materials: human rccombinant IL-I(j and 
IL-Ia (Biogen, Geneva) by councsy ofDrs. A. Gronenbom (Max Planek 
Institu te for BiochemiSlry, Maninsreid) and P. WingJ1e[d (Biogen, Ge-
neva), bovine reeombinant basic fibroblast growth faetOT (bFGF) (Pro-
gen. Heidelt)Crg) by eounesy ofDr W. Risau (Max Planek Institute for 
Psyehiatry), human recombinant insulin-like groWlh factors land 11 
(IGF- I and IGF-II) from Dr. A. Skottner of Kabi Peptide Hormone 
(Stockholm), and the gangl ioside mixture (composition: GMI :GD la: 
GDlb:GT lb - 20:43:15:19), originally prepared by Fidia, ltaly, from 
Drs. Y. Arakawa and H. Qz.awa of Eisai Phannaceuticals Co. Ltd. 
(Tokyo). NGF purified from mouse submandibularg.!and (for rtference, 
see Saadat el al., 1989), brain~erived neurotrophic faetor (BDNF) pu-
rirte<! from pig brain (Hofer and Barde, 1988), and eiliary neurot rophic 
faeloT (CNTF) purified from rat sciat ic nerves (Saadat ct al. , 1989) werc 
provided by Drs. H. Rohrer, Y._A. Barde, and M. Sendiner, respeclively, 
from our laboratory. Batehes of protein factors from commereial sources 
used in this study have shown biologic'al act ivity in other systems (for 
IL-Ia, IL-I ß. EGF, bFGF, POGF: Spranger et al. , 1990; for IGF-I and 
IGF-I1: Arakawa ct al. , 1990). Ncurotrophic factors purified in the lab-
oratory (NGF, ßDNF, CNTF) were full y aetive in the appropriate bio-
usay. All the other ehemicals were of reagent grade. 
Cell umJ "'gun ,·ultuTe. SdlW .. "" u:lIs wen: pl cpared by a modif'C3l ion 
of published methods (Poner et al. , 1986). Scialic nerves were dissected 
from 2-]-d-old Wistar ra ts and treated with 0.1% collagenase (Sigma) 
in Ca" _Mg1+ _frec POS for 40 min and funher ineubatc:d with 0. 1"-
trypsin for 20 min . After trituration with a Pasteur pipclte, dissociated 
cells wcre plated on 6 em dishes in DMEM supplernented with 10% 
FCS (10% FCSlDMEM) and antibiotics (100 Utml penieillin and 0.1 
mg/mI streptomycin). Cclls were exposed to two cycles of Ara-C treat-
ment ( 10 }'M) for 3 d eaeh to eliminalc proliferaring fibroblasts. After 
7 d , cells were washed, split, and plated on poIY-L-lysinc-coated 6 cm 
dishes in 10% FCSlDMEM containing IO},M FK and antibiotics. The 
cells were cultured for a maximum of 8 d in the pTe5ence of FK. Qnce 
conftuenl, medi um was ehanged to 10% FCS/DMEM eontaining anti-
biotics followed by the same medium change evcry third day. Expanded 
Schwann cells wert! subculturetl uncc mon;: fOI' cxpt:rimcnts aRel at least 
1 week without FK. Purity ofSchwann cells was higher than 98% when 
evaluated by immunostaining for NGF receplor (Chandler et al., 1984) 
[antibody Mel92 ... as a gcnl'rous giR ofOn. E. Shooter (Stanford Uni-
versity) and M. Hosang(Hoffman-LaRoche, Basel)1 and S-IOO protein, 
... hich in the PNS is a spc:cific marker for Schwann alls (Slcfansson CI 
at. , 1982) (rabbi! '\nti~C<)w S-IOO [rom Dako, Copcnhugen). 
Adult rat sciatic fibroblasts and explant cul tures of ra t sciatic nerve 
segments were prcparcd as described by Lindholm et at. (1988) and 
Heumann el al. (I 987b), resJ)CCtively. 
Thc medium used for stim ulation of cells and nerve segments was 
10% FCS/ DMEM uniess otherwise stated. Wherc specilied, 1% FCS/ 
DMEM or a serum-free medium consisting oCa I: I mixture of Ham's 
FI2 medium and MEM containing a modified N: supplement (eon-
tainins 30 nM se[enium, [00 11M putrescine, 5 lIg/ml insulin, and I mg/ 
ml transfemn, but no progesterone) was used (Bottenstein and Sato, 
1979). 
Sympathetic neurons were obtained from superio r cervieal ganglia of 
newbom rats and cultured in serum-free medium (see Saadal et al.. 
1989). 
RNA puparalion and Nor/hun bio/ analysis. Total RNA was prepared 
from cells and tissue that had been kept frolen after st imulation ac-
eording 10 the method of Chomczynski and Saeehi ( 1987). The u trae-
tion buffer oontaincd 20 PS of a O,!5I -ldlobase (Kb)-I<mg NGF standard 
RNA to evaluate thc recovcry of mRNA. Total RNA sampies and 
different amounts offull-[ength NGF-mRNA standard were g1yoxy[at-
ed, e1ectrophoresed through a 1.5% agarose gel, and thcn transferred to 
a nylon membrane (Hybond-N, Amersham). Following transfer, mem-
branes were fixed by UV irradiation, prchybridized, and hybridized 
with " P-Iabeled NGF-cRNA probc(O. 92 Kb)at 68"C in 50% fonnamide 
(see Heumann el al., 1987a). The membranes were washed and exposed 
to Fuji RX films al - 80"(: for 12-]6 hr. The amounl ofccllular NGF-
mRNA present was quantified by densilomelric scanning (LKB UI-
lrosean XL) ofthe autoradiograms and correction for RNA recovery. 
NGF ELISA. Thc amount of NGF in the medium ofSchwann teils 
was measurcd by a sensit ive two-site ELiSA (Korsching and Thoc:nen, 
1983) with recently describcd modifications (Spranger et al., 1990). 
Results 
1:..1[«t 01 peplide growlh lactors on Nü F-mRNA lnels in 
cuflured Schwann cel1s 
EJI,prcssiVIl ur NGF-mRNA \t:vcls in ~ult un.:d Schwann eells 
prepared fro m ncwbom rat seiatic nerves was examined by 
Northern blot. Schwann cells kepl in serum-containing medium 
(10% FCS/DMEM) and in serum-free medium contained 5.63 
± 2.30 (f! = 35) and 2.00 ± 0.99 (n = 7) pg of NGF-mRNN 
1()6 cens, respe<:tively. Addition of 10% FeS 10 Schwann eells 
kepl in serum-free medium led 10 a gradual inercase in NGF-
mRNA levels that d id not becomc apparent before at least 24 
hr after m edium change. This is in contrast to Ihe rapid and 
m assive response of astrocytes to serum (Sprangcr CI al. , 1990). 
Since the present study was initiated by the prcviously observed 
more than lO-fold increase in NGF-mRNA levels after lesion 
of the sciat ie nerve, we focuscd our a ttentio n on ehanges in 
NGF-mR NA levels o f more than twofold . 
IL-I has been shown to increase NG F-mRNA levels in a 
variety of system s, including explant eulture of seiatie nerve 
Sl.""gIllCll ts, f,brob1ast:; i~v[atoo frV III st:"ial i ~, astnx;ytt:1S in culturc , 
and hippocampus in vi\'Q (Lindholm CI a\., 1987, 1988; Spranger 
et al. , 1990). PDGF has a lso been shown to increase NGF-
mRNA levels in cxplant cullures of seiat ie nerve segments 
(Lind holm el al., 1987). EGF and bFG Fwerc shown toaugment 
NGF-m RNA levels in cultured astrocytes (Spranger el al.. 1990). 
Thereforc, Schwann cells werc treated with growth factors and 
cytokines including PDGF (Aß and 88), EGF, bFGF. IGF-I , 
IGF- II, and 1L- 1.6 fo r 3--6 hr, either individually in thc prcscnce 
of various serum eoncentrations (1 0%, 1%, o r serum-frcc) or 
after prctreatmcnt with FK (24--48 hr). None ofthese conditions 
revealed an influencc ofgrowth factors or cytokines o n the NGF-
mRNA levels in Schwann eells (for ineubation with ind ividual 
factoTS, see T able 1). IL- Ia a lso had no elTecL In addition, we 
Tlible I . EReets of peptide growth factors lind C)'tokines on the level or NGF-mRNA In cultured 
Schl"ann ttlls 
Time NGF-mRNA 
Factor Concentration (hr) (% of oontrol) 
EGF 10 nglrol 3 100 
6 81 
bFOF 20 nglml 3 84 
6 95 
IGF- I I pglml 6 84· 
II ll()o 
IGF-II 0.5 Jjglml 6 95· 
II 1(J()o 
Porcine POOF-BB 10 ng/ml 4 95 
6 94" 
Human POOF-AB 10 nglml 3 92· 
6 82· 
II 86-
IL-I ,6 30 V/ mi 6 99 ::t: 1 6~ 
NGF 50 nglml 3 99 
6 70 
BDNF 30 nglml 3 76 
6 93 
CNTF 2 nglml 3 94" 
Schwann teils (0.4-0.6 .. 10" cclb) weil: trcated wi tl! ractors in strum-frtt medium (EGF l nd bFGF) or 10'Ii0 FCSI 
DMEM medium (rest of the faclors) for the indicated time befoll: euraclion. The dall Ire Ille mean of duplicate 
dttenninations unless indiClled otncrwist . 
• SinaJe dettnninat ion . 
• Mcall ;t SO (11 - S). 
tested ncurotrophic proteins, whieh are synthesized in thc sciatie 
or by Schwann ceHs. Howcver, the addition of NGF, BDNF, 
and CNTF had no essential efTects on the NGF-mRNA content 
(Table I). The effcct ofTGF-,8 1 is described separately. 
t::o"ec( 0/ axonal conlac( 
Jn the adu ll animal , Schwann eells exist in close axonal eontact. 
To study the influence ofaxonal contaet, we analyzed a neuron-
Schwann eel l eoculture system. Pure cultures of superiorccrv ieal 
ganglionic neurons from ncwbom rals, wh ich in the presenee 
of NGF extcnded a rieh neurite network on lami nin, were re-
plenished with pure Schwann eells. Nearly all Schwann ccJ1s 
established eontact with axons and maintained eontaet for the 
entire euhure period (Fig. I). After 3 d in vitro. the cocultures 
werc stim ulated with IL- I,8 or FK (sec below for the stimulatory 
effcet of FK on pure Schwann cell cultures). Cocu lture did not 
rcsult in IL-I ,8 responsiveness, nor did il change the induetion 
of NGF-mRNA by FK (data not shown). Basal levels ofNGF-
mRNA wcre elevated approx imate]y 1.5-2-fold compared 10 
isolated Schwann cells. This may be duc to the initiation of 
Schwann cell proliferation by axonal eontaet (Wood and Bunge, 
1975). 
Gangliosides have bccn reportcd to increasc steady state NGF 
levels in culture medium ofSchwann eells (Ohi et al. , 1990). fn 
our experiments, a mil'.ture of gangliosides obtai ned from the 
same sou rce and applied at I mM (average concentration) for 
3-24 hr toSchwann cells eulturcs did not result in any significant 
inerease in NGF-mRNA levels (dat3 not shown). 
Regulation o/rhe NGF-mRNA level in Schwann cells by 
cAMP 
/:..1[ecl 0/ FK. cAMP analogs. and ,8-adrenergic receplor agonislS. 
Treatment ofSchwann cells cultivated in 10% FCSlDMEM with 
FK, 3 reversible activator oradenylate cyclase. for 6 hr resultcd 
in a six- to eightfold inerease in NGF-mRNA levels, irrespeetive 
of the prcscncc of I L-l ,8 (Fig. 2. upper lanes). In serum-free 
medium, although the basal levels of NGF-mRNA are de-
crcased, FK sti ll exerted a 2.7-fold induction of NGF-mRNA 
(Fig. 2, lower lanes). Treatment of Schwann eells with 8-8r-
cAMP and N'-benzoyl-cAMP, membrane-permeable analogs of 
cAMP, also inereascd the NGF-mRNA (Fig. 3A). The order of 
poteney of cAMP analogs (i.e., JVt>-benzoyl-cAM P > 8-Br-cAM P) 
was in aecordanee with other eAMP-dependent systems such 
as lipolysis in adipocytes(Beebe et al., 1984). Dideoxyforskolin . 
a FK analog that possesses most ofthe cAMP-independent ef-
feets of FK but lacks the ability to activate adenylate cyclase 
(see Lauren"l3 et al., 1989), did 'not increasc NGF-mRNA levels 
(Fig. 3A). The incffcctiveness of 8-bromo-cGMP (8-Br-cGMP) 
indieatcs that activation of guanylate eyclase does not playa 
role in induetion ofNGF-mRNA. 
Norepi neprine and isoproterenol. ß-adrenergic receptor ag-
onists already shown to inerease eAMP leve)s in Schwann cells 
(Yasuda et al. , J 988), also incrcased NGF-mRNA to levels sim-
ilar to those aehieved by FK treatment (Fig. 38). In contrast, 
clonidin, an lr-adrenergic receptor agonist that docs not affcct 
cAMP levels, did not change thc NGF-mRNA content . The 
induetlon of NGF-mRNA by norepincphrine was abolishcd by 
meloprolol, a specific ß, -adrenergje rcceptor antagonist (Fig. 
3B). CGRP, which has been reported 10 increase cA MP in other 
cell types (Laufer and Changeux, 1987; villar et al., 1989), did 
notgivesignifIcantchanges in the NGF-mRNA levels in Schwann 
eells (1.3-fold incrcasc for CGRP). 
Primary Schwann cells that were prepared from newbom rat 
sciatic nerve and Ara-C treated as described but without ex-
pansion by FK also responded 10 FK by an incrcase in NGF-
mRNA levels eomparable to expanded cultures. Again , they did 
not respond to IL-I (data not shown). Thisobservation indieatcs 
that FK administered in order to achieve the large cell numbers 
nccessary for the Northem blot experiments does not pcrma-
nently change Ihe regulation ofNGF synthesis in Schwann cells. 
Figure J. Schwann cells in contact with axons. Neurons were prepared 
from newbom rat superior cervical ganglia and allowed to form exten-
sive neurite network for 3 weeks. Schwann cells were then plated directly 
on the neurite network and further maintained in culture for 3 d. Top, 
Phase-contrast micrograph. BOI/am. Immunostaining of Schwann cells 
for S-IOO. &ale bar, 50 "m. 
The concentration dependence ofthe FK induction ofNGF-
mRNA in Schwann cells was measured. As shown in Figure 4A, 
NGF-mRNA in serum-containingmcdium was maximally(8.3-
fold) induced by 30 J.lM FK, and the half-maximal concentration 
was approximately 6 ~M. These values are in the same range as 
those reported for the elevation of intracellular cAMP by FK 
(Scamon and Daly, 1981). The concentration dependence of 
NGF-mRNA induclion by FK in serum-free medium was sim-
ilar to that in serum-containing medium (data not shown). 
Analysis ofthe time course ofthe FK cffect on NGF-mRNA 
(Fig. 48) showed that the level of NGF-mRNA increased dras-
tically bctwecn land 3 hr after thc addition of I 0 ~M FK, reached 
a plateau bctween 3 and 6 hr, and thereafter gradually decreased 
10 less than twofold at 24 hr(Fig. 4B). The level ofNGF-mRNA 
48 hr after addition of FK was almost equal to thc basallevcl 
before cxposurc to FK. Induction of NGF-mRNA by 0.1 mM 
isoproterenol showed kinetics similar to that of FK, reaching 
its maximum at 3 hr (Fig. 4B). However, the level of NGF-
mRNA retumed 10 the basal level 6 hr after addition of iso-
proterenol. This cffcct may bc due to thc desensitization ofthe 
ß-adrencrgic receptor. 
Modification olthe FX ejJeet by ionomycin and TPA. Treat-
ment ofSchwann cells for 3 hr with I ~glml ionomycin, a Ca2+ 
ionophore, slightly incrcased the NGF-mRNA level (twofold 
from the basal level; Fig. 5A,B). However, when ionomycin was 
added together with FK at 20 J.lM , wherc the FK effect itselfwas 
almost maximal (see Fig. 4A), the NGF-mRNA level in Schwann 
cells increased markedly to 15-fold the basal level (approxi-
mately twofold the level increased by FK alone; Fig. 5A,B). This 
elfect of ionomycin was abolished by 5 mM EDT A, a chelator 
of divalent cations (data not shown). Application of ionomycin 
together with either 0.1 mM norepinephrine or 0.1 mM isopro-
terenol again resulted in a synergistic increase of the NGF-
mRNA, reachinga level12-fold higher than the basal level (data 
not shown). 
TPA, a phorbol ester and potent activator of protein kinase 
(PKC), exerted opposite effects on the basal as comparcd to FK-
induced levels of NGF-mRNA in Schwann cells. Treatment of 
Schwann cells with 0.1 ~g1ml TPA for 3 hr significantly reduced 
the basal level of NGF-mRNA (to approximately 30% of the 
basal level), while treatment with TPA in the presence of FK 
remarkably increased the NGF-mRNA to a level (approxi-
matdy 13-15-fold of basal level) similar 10 the level induccd 
by combination of ionomycin and FK (Fig. SA,B). Treatment 
ofSchwann cells with ionomycin, TPA, and FK all at one time 
elevated the level ofNGF-mRNA slightly more than either of 
the combinations ionomycin and FK or TPA and FK. 
Ejfects o!inhibitors o!proteinphosphorylation.ln mammalian 
systems, most ofthe elfects of elevated cAMP on cellular events 
are shown to bc mediated by activation of cAMP-dependent 
protein kinasc (PKA) (Edelman et al. , 1987). Therefore. we 
investigated the putative role ofprotein phosphorylation in the 
regulation of NGF gene expression using the protein kinase 
inhibitors H- 7 and H-8. In a cell-free system, H-7 was shown 
to bc selective for PKC(K, = 6.0 ~M), while H-8 is moreselective 
for PKA (X, = 1.2 ~M) than fOT PKC (Xi = IS J.lM) (Hidaka et 
al., 1989). As shown in Figure 5B. pretreatment of Schwann 
cells with H-7 up to 50 J.lM did not reduce the levels ofNGF· 
mRNA in most ofthe conditions used. However, the effect of 
a combination ofTPAand FK was reduccd by 50 ~M H-7 dose 
to that achieved by FK alone, suggesting a role ofPKC activation 
in the enhancement ofFK action. On thc olher hand, pretreat-
ment ofSchwann cells with 50 J.lM H-8 drastically reduced the 
NGF-mRNA levels under all experimental conditions tested 
(Fig. SB). Thus, H-8 suppressed not only the elfect of FK, but 
also the potentiating elfects ofTPA and ionomycin. It also re-
duced thc basal NGF-mRNA levels to nearly undetectable val-
ues. 
EjJects 01 cycloheximide. Cycloheximide, an inhibitor ofpro-
tein synthesis, is known to affect the levels of various mRNAs 
by eliminating short-lived proteins responsible for either tran-
scriptional repression or destabilization ofmRNAs (Shaw and 
Kamen, 1986). As shown in Figure 6, incubation ofSchwann 
cells with 10 ~glml cycloheximide for 3 hr resulted in an increase 
in NGF-mRNA levels comparable to the level measured after 
FK treatment. Concomitant application of cycloheximide and 
FK to Schwann cells resulted in an additive elfect on NGF-
mRNA levels, suggesting that synthesis oftranscriptional acti-
vators is not required for the action of FK. 
Stability 01 the NGF-mRNA in Schwann cells. The half-life 
ofNGF-mRNA was measured by following the time course of 
the decay ofNGF-mRNA after the addition ofactinomycin D. 
a transcriptional inhibitor, to cells stimulated with FK. iono-
mycin, or cycloheximide (Fig. 7). The results are summarized 
in Table 2. NGF-mRNA in Schwann cells without stimulation 
2.6 2.3 15.1 11.4 0.9 
285-rANA --
NGFmRNA ------.. 
51andard .. 
1.9 1.3 5.1 6.0 0.4 0.4 
285-rANA-
NGFmRNA ----+-
51andard .. 
IL-1ß + + + 
FK + + 
TGF-ß1 + + 
had a half-life (I"' ) ofO.67 hr. Cycloheximide clearly prolonged 
the half-li fe 3A-fold, suggesting that at least part ofits effect is 
on the stabilization of NGF-mRNA. On thc other hand, FK, 
which increased the NGF-mRNA content 10 higher levels than 
cyclohcximide, did not significantly prolong the half-life ofNGF-
mRNA. lonomycin, which increased the steady state NGF-
mRNA level about twofold, also failed 10 prolong the lifetime, 
Table 2. Stability of NGF-mRNA in Scb'ann teils 
Half-life (tJ of NGF-mRNA 
4.5 3.1 (pg) 
1.8 1.9 (pg) Figure 2. Northem blot analysis of 
NGF-mRNA ;, Schwann cells. 
Schwann cells (6 " 10' cells/dish) kepl 
in serum-containing medium (10% 
FCSIDMEM; upper lanes) or serum-free 
medium (fower lanes) for 24 hr \\lCre 
treatecl with FK (10 pM) for another 6 
hr before the cells were fraun. Where 
indicaled, the cells were treated with 
IL-I {J (30 Ulml) for the last 3 hr before 
freezing or pretreated with TGF-P I (2 
nglml) starting 6 hr before addition of 
FK. Tbc shon length standard (0.51 Kb, 
20 pglsample) was incJuded in the ex-
tmction buffer to allow fOT eorrection 
of RNA retovcry, and its position is 
indicale<! by the a"owhead. Tbc posi-
+ 
tion ofthe full-length NGF-mRNA (1.4 
Kb) is indicated by the a"o.". Values 
+ + above lanes indieate the absolute 
+ + 
amount ofNGF-rnRNA (pg) after cor-
reclion for RNA recovery. 
whilc thecombination ofFKand ionomycin prolonged the half-
life about twofold. 
Effect o/ TGF-ß I on NGF-mRNA levels in Schwann cells 
It has recently been reported that TGF-ß I and TGF-ß2 are 
milogcnic for rat sciatic Schwann cells and aet synergistically 
with FK on the proliferation ofthese cells (Eccleston et al. , 1989; 
Addition h< Relative' 
Levelof 
NGF-
mRNA~ 
(relative) 
No addition 0.61 
lonomycin 0.16 
FK 0.85 
FK + ionomycin 1.5 
CycJoheximide 2.3 
Values a~ ealculated from the experimenu oF FigUR 7 . 
• Relative to h.alf-life detennined fOT nontrea!ed cells . 
1.13 
1.21 
2.24 
3.43 
I 
1.85 
3.93 
12.6 
2.86 
• Amount of NGF-mRNA after drug treatments just before actinomycin D addition. Values are given relative to 
nontreated cells. 
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Figure J. Effect of FK aod cAMP aoalass and ,,-adrenergic receptor-
related substances on the level of NGF-mRNA in Schwann cells. A, 
Schwann a: lIs were incubated with 10 /olM FK, 10 /olM didcoxyforskol in 
(DFK), 1 rnM 8-bromo-<:AMP(88r.A), 0.5 mM N"-benzoyl-cAMP(6Bz-
A), t rnM 8-bromo-cQMP (88r.G), or a combinal ion thereof for 6 hr . 
B. Schwann cells were incubated in the presence ofO.5 mM 3-isobulyl-
\-methylxanthine (lBMX) with 0.1 m M norepintphrine (NE), 0. 1 mM 
isoprotereno l (I?), 0.1 mM clonidin (Clo), 0.1 mM metopro lo] (M et), 10 
.uM FK, or their combination for 3 hr. Nonhem blot analysis was per-
forme<! as in Figure 2. Levels of NGF-mRNA were calcula ted as de-
scribed in Materials aod Melhods. In A. each column represents the 
mean and range (indicated by broken lines) of duplicate sampies ellcept 
for 8Br-G (single detemlination). In B. ach colullm represents the mean 
and SO of triplicate sampies Cllttpt for Mn and NE+ M et (duplicate 
det t nninations) and eiD (single detcnnination). 
Ridley et al. , 1989). Funhennore, TGF-ß I increascd the NGF-
mRNA levels in astrocytes in culture 50-fold (Lindholm et al. , 
1990). These observations prompled us 10 examine Ihe effecl 
ofTGF-,B 1 on Ihe level ofNGF-mRNA in Schwann cells in the 
presence and a bsence of FK. As shown in Figure 2, treatment 
o f Schwann cells with TUF-.B I (2 nglml) decrcased the NUF-
mRNA levels hath in the presence and absence o f serum. As 
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Figure 4. Dose- and time-dependent increase by FK of the level of 
NGF-mRNA in Schwann etlls. 14, Doso-response. Schwann cells were 
incubated with the indicated concenlration ofFK for 6 hr before freez-
ing. Each data point represents the mean and range (indicatcd by the 
broken /in,) of duplicate sampies. B, Time course. Schwann cells were 
frozen il t the indicated time after addition of I 0 ~M FK (open eireles). 
A representative ofthree independent ellperiments is shown. Time course 
ofNGF·mRNA increase induced by 100 ~M isoproterenol in the pm· 
cnce ofO.5 m M 3-isobutyl-l-melhylxanthine is also shown (solid elfdes; 
mean ± SO; n - 3) . 
shown in Figure 8A. Ihe basal level of NGF-mRNA staned tO 
decrease between 3-6 hr after addition ofTGF-,B I. We analyzed 
the minimal time of pretrealment necessary for the effec! of 
TGF-ß. When Schwann cells were pretreated with TGF-ß I for 
various periods beforc addition of FK for another 3 hr, a sig-
nificant inhibition ofTGF-,81 on the FK-induced NGF-mRNA 
became det«:table with pretreatment periods longer than 6 hr 
(Fig. 8B). When TG F-,B I was added simultaneously with FK, 
the inhibitory effect of TGF-,81 stancd after 6 hr (data not 
shown). The effee! ofTGF-,8 l was transient, since it was not 
obscrved after 24 hr pretreatment (Fig. 8B). The effect ofTGF-
PI was maximal at 2 nglml (Fig. sq. 
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Figure 5. Elfecl of Ca" ionophorc, TBA, FK, and inhibitors of protein phosphorylation on thc level of NGF-mRNA. A. Schwann cells wert 
treated for 3 hr with a combination of the fo l1 owing reagenlS: ionomycin (Jon; 1 ..,glml), TPA. (0. 1 " glml), and FK (20 ,<I M). B. Schwann cells wert 
pretrcalcd with 20 or 50 /iM of H-? or H -S for 0.5 hr and then FK (20 pM), ionomycin (iollo; I /Jglml), aod TPA (0. 1 ... glml) or combinations 
thereof wert added for another 3 hr. Each <lata point represents thc mean aod range (indicated by broken fines) of duplicate sampies. 
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Figure6, Effccl of cyclohcximidc on thc level ofNGF-mRNA. Schwann 
cells werc treated for 3 hr with thc following rcagcnts: cycloheximide 
(CHX; 10 ,«glml), ionomyein (lONG or 1; I pg/ml), or FK (20 ,11M) OT 
combinalions IheTeof. Each data point reprcscnts thc mcan and range 
(indicatcd by broken Unes) of dllplicatc sampIes. 
Effeci o[ FK, iOllomydn. and TGF-ßI on the concentration 0/ 
NGF protein in the medium 0/ Schwann cell cultures 
NGF protein accumulating in the culture medium during 24 hr 
incubation with FK, ionomycin, and TGF-ßl was measurcd by 
a two-site ELiSA (Fig. 9). FK increased the NG F concentration 
1.7-fold. Concomitant apptication ofFK and ionomycin showed 
a remarkable increase in the NGFconcentration (4.6-fold). TGF-
ßl (4 nglml), addcd logcthcr with FK,abolishcd the FK-ind uced 
increase in NGF protein in agreement with the effect ofTGF-
ß1 on the NGF-mRNA as describcd above. TGF-ß I added 
alone also gave a small decrease in basal NG F concentration. 
Our intention was to demonstrate that the changes of NGF-
mRNA levels are paralleled by ehanges in the amount ofsccreted 
protein. Therefore, we did not attempt to optimize the recovery 
ofNG F protein from Schwann cell conditioned medium by the 
indusion of protease inhibi tors. 
Comparison ofthe effects of FK and IL-J on the NGF-mRNA 
levels in nerve organ culrure and sciatic fibroblasls 
To assess the question whether FK also acts in the complex, 
nondissociated tissue, we performed experiments on ncwbom 
and adult rat sciatic nerve organ culture and fLbro blasts prepared 
from adult rat sciat ie. As shown in Figure IOA, treatment of 
explant culture of newbom rat seiatie nerve segments (a nimals 
were ofthe same age as those used for Schwann cell preparation) 
with IL-1ß for 3 hr increased NGF-mRNA eightfold . FK at 20 
~M also inereased the NGF-m RNA signiftcantly(fivefold). lono-
myein, whieh itsclfhad no effcct, enhanced the response to FK 
inereasing the NGF-mRNA levels sevenfo ld.lonomycin did not 
furt her elevate the IL-Iß-med iated increase in NGF-mR NA 
levels (data not shown). In adult sciatic nerve explant culture, 
20 ~M FK had an efficacy almost CQ uivalent to that of IL-Iß 
(Fig. J 08). lonomycin did not furthcren hance the effcct ofeithcr 
IL- Iß or FK. In eultures offibroblasts prepared from adult rat 
sciatic nerves, FK was less effective than IL-lß (Fig. lOG). 
Discussion 
A major concern regarding the in vilro approach chosen in this 
study may be its relevance for the in vivo sit uation. Schwann 
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Figure 7. Stability of NGF-mRNA in Schwann cells. Schwann rells 
were treated with FK (20 ~M), ionomycin (iOflO; I ~g/nl l), or cyclohex· 
imide (CHX; 10 Jlg/ml) for 4 hr. Then transcription was blocked by 
adding 10 ~g/m l aC1inomycin 0, and reHs were further incubatoo for 
the indicatoo time. The NGF-m RNA levels at 4 hr (before addition of 
actinomycin D) are set at 100%. Each data point represents the mcan 
oftwo to four sampies (each individual data point did not deviate more 
than 1 S% from thc mean). 
cells prepared from seiatic nerve and sti mulated to proliferate 
in vitro have been shown to re tain basic Schwann cell properties 
and remain fu nctionally compctent (Dubois-DaJcq et al., 1981 ; 
Porter et al., 1986; Rutkowski et a1., 1990). Particularly, the 
effects of the comlXJunds used for cell seleetion and induelion 
ofSchwann cell proliferation are reversible. This interpretation 
is supported by our observation that the expansion of the 
Schwann cell cultures by FK did not change the regulation of 
NGF-mRNA. Furthermore, the regulation by cAMP was largely 
independent ofthe cell environmentand wasdetected in purified 
cultures as weil as in nondissociated nerve segments and Schwann 
ccll-ncuron eoeulture. Si nce for teehnical reasons large n umbers 
ofSchwann cells eould only be obtaincd from newbom animals, 
we also analyzed the response to IL-l and FK of newbom in 
eomparison to adult nerve organ culture. No age-depcndcnt 
differences in NGF-mRNA regulation were detectable. 
In the following, we d iscuss the main eharaeteristics of NG F 
regulation in Sehwann ccHs, that is, the ineffcctiveness ofgrowth 
factors to increasc NGF-mRNA levels and possiblc molccular 
mcchanisms responsible for the regulation by cAM P; moreover, 
wc emphasize the striking differences bctween the NGF regu-
lation in Schwann eells and that in various other ccll types. 
Regulation by growth faclors 
The available data show that IL-I is a potent regulator ofNGF-
mRNA expression in sciatic nerve and fI broblasts (Lindholm et 
al., 1987, 1988). IL-I has also becn shown to increase NGF-
mRNA in cclls and tissues of the CNS, that is, in eullured 
astrocytes and in thc hippocampus after inlravcntricular injcc-
tion (Spranger el al., 1990). The inabili ty of Schwann cells to 
res pond 10 IL-I does not seem to be duc to lack oflL-1 receptors, 
since by using iodinated IL- I we found spccifie IL-I binding 
sites on Schwann cells with an affmily constant comparable 10 
that described fo r typical IL-I responding cells (M. Meyer and 
H. Thoenen, unpublished observations). Furtherrnare, prelim-
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Figur" 8. Effect ofTGF-{H on the level of NGF-mRNA in Schwann 
cells. A. Elfecl ofTGF-pl on thc basalleveJ ofNGF-mRNA. Schwann 
cells were treated wilh 2 ng/ml TOF-PI for thc time indicatcd. B, Effecl 
ofTGF-ßI on thc FK-stimulatcd level ofNGF-m RNA. Schwann teils 
wert preincubaled wilh 4 nglml TGF-ßl for thc time indicated and 
then furtller incubated wilh 20 I'M FK for 3 hr. Broken lines indicate 
Ihe range of duplicalc sampIes. C, Dose dcpcndcncc of the TOF-pl 
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Figur" 9. Effeci of FK and TOF-tll on thc NGFconcentration in the 
medium ofSchwann cells. Schwann cells wert incubatcd wilh (resh 10% 
FCSlDMEM (1 ml) thai containcd 20 I'M FK, 4 ng/ml TGF-t3l, or 1 
"glml ionomycin (ION), or their combinalion for 24 hr. After Ihe in-
cubation pcriod, the culture medium was collected and the NGF con-
rentrat ion was measured by ELISA. Each data point indicates mean 
and range (indicatcd by blaken fines) or duplicate sampies. 
inary quantiflcation of IL-I bioactivity in Schwann cell condi-
tioned medium gave no indication ofautocrine IL-l production, 
which could result either in saluration of the IL-I response or 
in descnsitization. This suggests that the Schwann cell IL-I re-
ceplor, in contrast to its counterpart on astrocytes and fibro-
blasls, is funclionall y uncoupted from intracellular meehanisms 
of NGF regulation. OUT Schwann cell-neuron coculture exper-
iments show that coupling does not simply dcpend on axonal 
contaet, although it may be argued that OUT culture conditions 
did not warrant an ill ~'ivo type of contacl. We cannot exc1ude 
that culture conditions thai promote extensive enshealhment 
and basal lamina formation (Bunge CI al., 1986) would givc 
different results. OUf experiments revealed a similar situation 
for POGF and bFGF. In Schwalm cells, these growth factors 
regulatc cell proliferation and c-fos mRNA levels (Ramer et al., 
1988; Davis and Stroobant, 1989; Weinmaster and L.emke, 
1990), but, again in contrasilo astrocytes (Spranger CI al., 1990), 
Ihey have nocffcct on Ihc levclsofNGF-mRNA. Sincc Schwann 
cells possess Ihe low-affinilY NGF rcceptor (DiStefano and John-
son, 1988; Yasuda el al. , 1987), wc tesled Ihc possibililY of a 
feedback controt. However, addition neither orNGF nor ofthe 
structurally rclated ßONF (Leibrock el al., 1989) rcsulted in 
any significanlchangeofNGF-mRNA levels. Also, CNTF, which 
is produced by Schwann cells in thc intact scia lic nerve (Lin cl 
al., 1989; Stöckli cl al. , 1989), did not significantly change NGF-
mRNA levels. 
Surprisingly, TGF-ßI downregulaled NGF-mRNA levels in 
Schwann cclls. A similar ralher slow action of TGF-ß has bccn 
elfect on the level ofNGF-mRNA. Schwann cells were incubated first 
wilh TGF-ßl at the indicated concentrations for 6 hr, alld then the cells 
were further incubated with 20 ~M FK for 3 hr (open eire/es). The basal 
level or NGF-mRNA ofthe reHs without FK and TGF-ß I treatments 
is also indicated (solid cüe/e). A typical example of two independent 
experiments with similar results is shown for A-C. 
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Figure JO. Comparison of thc eITects of IL-Iß and FK on thc levels 
of NGF-mRNA in explant culture of sciatic nerve from newbom (A) 
and adult (D) rau and fibroblasts from adult sciatic nerve (C). Nerve 
cxplants and libroblasts were incubated with /L-t (60 Ulml), FK (20 
pM), or ionomycin (lOND; I pg/ml) or combinations for 3 hr. Each 
column givcs thc absolute amount of NGF_mRNA (pglcxplant). Thc 
mean and range (indicated by broken fines) of duplicalc sampies are 
given. 
describcd in endothclial cell culturc, whcrc thc cffccts of bFGF 
werc suppressed by TGF-ß (Saksela CI al., 1987). Thc moleculn 
basis for these diffcrcnccs in NGF-mRNA regulation between 
astrocytes and Schwan n cells remains to be cl ucidated. Cis-
acting seQuences mediating transcriptional repression by TGF-ß 
have been identified in the promoter of the transin gene (Kcrr 
et aJ. , 1990); however, difterences in the trans-acting factors 
would have to account for cell type specificity. 
Mechanism ojregulalion by adenylale cyclase 
As a second approach for analyzing NGF regulation in Schwann 
cells, we analyzed the involvement ofsecond messengers. Using 
different analogs of FK and cAMP, we have shown that the 
major signal transduction pathway leading to an increase in 
NGF-mRNA levels in Schwann cells involves activation ofad-
enylate cyclase, whereas PKC activation resulted in decreased 
NG F-m RNA levels. This is in contrast to the situation described 
for fibroblasts (\Vion et al., 1990). Activation of adenylate cy-
clase via the ß, -adrenergic receptor also resulted in augmentcd 
NG F-mRNA kvt:ls. Thisadcnylatccydas{.~cpcndcnl pathway 
is not specifie forSehwann cells; small increases in NGF-m RNA 
occurring after adenylate eyc1ase activation have also bcen dem-
onstrated in rat primary astrocytes (Schwartz and Mishler, 1990), 
in glioma cells (Dal Toso et al. , 1988; Sehwartz, 1988), and in 
the present study in fibroblasts derived from the seiatic. AI-
though protein kinase inhibitors are not absol utely selective for 
spcciflC kinases, considering the exc1usive effectiveness of H·g 
we propose protein kinase A activation as the next step of the 
signal ing pathway. FK inereases the NGF-mRNA levels in 
Schwann cclls with kinctics comparablc 10 Ihose in systems 
wherc a rclationship bctwccn transcriptional activation by cAM P 
and increase in steady state m RNA is established (e.g., Sasaki 
et al. , 1984; Schmid et a1. , 1987). In agreemen t with the as-
sum ption oftranseriptional activation ofthe NGF gene by FK, 
we did not observe any major infl uence of FK on NGF-mRNA 
stability. Preliminary transfeetion experiments using NG F-pro-
moter/chloramphenicol acetyl transferase (CAT) construets 
showed that CAT activity is inducib1e by FK , conflrming its 
action at the transcriptional level (I. Matsuoka, M. Meyer, and 
H. Thoenen, unpublished observations). lt will be interesting 
to see whether a typical cAMP response element (CRE), for 
examp1e, as describcd for the somatostatin gene promoter (for 
review, see Montminy et aJ. , 1990) or a different sequence, is 
involved. A multiplicity of trans-acting factors involycd m 
eAM P-mediatcd transcriptional activation have been identified 
(for an overview, see f-I abcner, 1990; Ziff, 1990). 
Although cAMP seems to bc an essential faetor regulating 
NGF expression in Schwann cells, the modulatory effects of 
Cal~ ionophore and phorbol ester point to a eomplell regulatiorl. 
It should again be stressed that the potentiating effects ofthese 
drugs were H-8 sensitive and dependent on adenylatc cyclase 
activation. The molecular basis fo r these observations may bc 
found either in posttranslational modifieations of Irans-acting 
factors (Gonzalez et al., 1989; Sheng et al. , 1990; Van Nguyen 
et al. , 1990) or by effects on upstream elements of the signaling 
pathway, sueh as modifIeation oradenylate cyclase acüvity (SU3-
den et al. , 1985; Rozengurt et al. , 1987; Yoshimasa et al., I 98'i). 
Observations made in fibroblasts and glioma cel ls suggest that 
synthesis of the immediate early gene product, e-Fos proteirl, 
plays an important role in the regulation ofNGF-mRNA (Mo:-
eheUI et al., 1989; Hengerer et al., 1990). The c- Fos-dependerlt 
transactivat ion of the NG F gene in fibroblasts is mediated via 
an activator protein I (A P- I) site located in the first intron of 
thc NGF gene (Hcngcrcr ct al. , 1990). Howevcr, in Schwann 
teils the rc lationship between the expression of c-Fos protein 
und NCF is no t establi shed. Conditions thut lead 10 high levels 
ofexpression ofe-fos mR NA and Ap·l binding activity (c.g., 
TPA or serum addition; M. Meyer, I. Matsuoko, and H. Thoe-
nen . unpublished observations) in Schwann cells da not rcsult 
in increased NGF-mRNA expression (see Results). These ob-
servations may suggest that functional AP-l complex formed 
in Schwann cclls after the appropriate stimulation can not, in 
contrast to fibroblasts , interact with the intronie AP-l site of 
the NGF gene and/or o the r components of the transcription 
apparatus in a way necessary for transcriptional activation of 
the NGF gene. In contrast to astrocylcs and fibroblasts, whcrc 
cyclohex im ide had an inhibitoryeffect on the induction ofNGF-
mRNA (Moccheui et al. , [989; Hengereret al. , 1990; Lindholm 
e t a l. , 1990; Wion et ar. , 1990), cycloheximide addcd I08elher 
with FK incrl;ased the NGF+mR NA level in an additive manner 
in Schwann ~e ll s. This resull suggests that de nOI'O synthesis of 
t ranscriptic-nal activalors is not neccssary for the elfect of FK, 
whieh is consistent with the idea that posttranslational modi-
fieation of p rccxisting CRE·binding facto rs might bc involved 
(sec reviews; Yamamoto et al., 1988). In contrast, transacti· 
vation o f genes via A P·I depends on de no ro c-Fos protein 
synthcsis (Schönthai ct at. , 1988). 
Regulation of intracellular cAMP levels has bcen shown, at 
least in \'itro, to bc importanl for Sehwann cell prOliferation and 
differentiation (Raffet al., 1978; see, e.g., Sobue and Pleasure, 
1984; Monuki c t aL, 1989). It is not c1car which additional 
factors are n eeded to drive the eel1s in one dircction or the other. 
The regulation of NGF-mRNA by cAMP elevation seems 10 
be more or less independent or additional factors since it re-
quired only a very simple c ulture medium, Furthermore, it is 
interesting to note that cAM P increases NGF-mRNA transient-
Iy, whereas ils effccts on markers of differentiation, such as 
galactoccrebroside and myelin gene induction, are observed for 
exlended perioos after t reatment (Sobue and Pleasure, 1984; 
Monuki c t a l., 1989). It is not c1car whether increases in cAMP 
content ofSchwann cdls occur also in ~'ivo. and moleeules rc-
sponsi ble re main 10 bc identified . Neurotransmitters and neu-
ropeptides acting on rcc:cptors coupled to adenylate cyc1asc are 
candidates, buttheir accumulation to cffect ive extracellular con-
centrat ions after nerve lesion has to bc demonstrated. The pres-
ence ofCGRP has bccn demonstrated in spinal motoncurons 
and dorsal root ganglion neurons(Rosenfeld et aL, 1983; Gibson 
CI al., 1984; Fontai ne el a1. , 1986; New and Mudge, 1986; Villar 
et a l. , 1989). It is not known at present whether Schwann cells 
respond to CGRP by elevation of cAM P as has bcen demon-
strated for m yotubcs (Laufer and Changeux, 1987; Villar el al. , 
1989). 
In conc1usion , a wide variety ofdifferent cell types, inc1uding 
several types ofglial cells and neurons (for rcfercnces, see Zafra 
et 011. , t990), can eApress NGF. Together with prcvious invcs-
t igations, we have shown he re that evcn in one tissue. namely 
the sciatic ncrve, different non-neuronal cell types show a sur-
pri sing multiplic ily of mechanisms of NGF regulat ion . To bc 
able to explo il the POtential therapeutical value ofsuch studics, 
Ihe molecular basis fo r these differences has 10 bc worked out. 
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